Page 8 - University of California - Riverside

Diseases, Conditions, Syndromes

Researchers develop molecular traps to target SARS-CoV-2

A research team led by scientists at UC Riverside and UCLA has engineered novel nanoparticles to serve as "molecular traps" to target SARS-CoV-2, the virus that spreads COVID-19. The traps bind to SARS-CoV-2 and prevent it ...

Immunology

Scientists discover new avian immunological pathway

A research team led by a biomedical scientist at the University of California, Riverside, has discovered a new immune pathway in chickens that viruses—such as those that tend to infect birds, humans, and animals and spread ...

Diseases, Conditions, Syndromes

Good parent bond = good COVID behavior

Containing the COVID-19 pandemic depends on the degree to which people exhibit prosocial behavior— behavior that benefits others. We wear masks to protect ourselves, but also our neighbors. We get vaccines to stop the spread ...

Inflammatory disorders

A more targeted therapy to treat inflammatory bowel disease

Biomedical scientists at the University of California, Riverside, propose a way for drugs to be more effective against inflammatory bowel disease, or IBD, in which the intestine undergoes inflammation.

Genetics

New hope for people living with a genetic cause of autism

Fragile X syndrome, or FXS, a leading genetic cause of autism, affects around one in 4,000 males and one in 6,000 females. Its symptoms include increased anxiety, intellectual disability, repetitive behaviors, social communication ...

Ophthalmology

Biocompatible glue for corneal repair

A biocompatible, antimicrobial adhesive for corneal repair and grafting could replace sutures and conventional adhesives with bad side effects.

page 8 from 34